JIANGSU YAHONG MEDITECH revenue for the last year amounted to 14.00 M CNY, the most of which — 9.37 M CNY — came from its highest performing source at the moment, Anti-tumor. The greatest contribution to the revenue figure was made by China — last year it brought JIANGSU YAHONG MEDITECH 9.37 M CNY, and the year before that — 26.10 k CNY.